AGN is going to go through phase 2. Drugs in this same class have already proven reducing calcium influx reduces brain injury.
- Forums
- ASX - By Stock
- Ann: New US Patent for Surgical Stroke
AGN
argenica therapeutics limited
Add to My Watchlist
0.00%
!
67.0¢

AGN is going to go through phase 2. Drugs in this same class...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
67.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $86.06M |
Open | High | Low | Value | Volume |
67.0¢ | 67.0¢ | 67.0¢ | $96.36K | 143.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 17984 | 67.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
71.0¢ | 5000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 17984 | 0.670 |
2 | 10760 | 0.660 |
2 | 45706 | 0.655 |
5 | 27350 | 0.650 |
1 | 2000 | 0.645 |
Price($) | Vol. | No. |
---|---|---|
0.710 | 5000 | 1 |
0.725 | 6000 | 1 |
0.780 | 29000 | 1 |
0.790 | 7000 | 1 |
0.810 | 65750 | 1 |
Last trade - 15.25pm 04/08/2025 (20 minute delay) ? |
Featured News
AGN (ASX) Chart |
The Watchlist
AFP
AFT PHARMACEUTICALS LIMITED
Hartley Atkinson, CEO & Founder
Hartley Atkinson
CEO & Founder
Previous Video
Next Video
SPONSORED BY The Market Online